Russell Szmulewitz, MD

Assistant Professor of Medicine

Russell Szmulewitz, MD, is an expert in the treatment and management of prostate, bladder, kidney, and testicular cancers. His clinical focus is on the treatment of patients with advanced prostate cancer, with particular expertise in the use of leading-edge hormonal, targeted, and immunotherapies. Dr. Szmulewitz works in close collaboration with urologists, radiation oncologists, and geriatricians who also specialize in the care of prostate cancer patients.

His research bridges the clinic and laboratory and focuses on the process of prostate cancer metastasis. In particular, his research attempts to better define the steps involved in metastatic progression and evolution to castration resistance in prostate cancer, with the goal of developing targeted therapies for these processes. In addition, Dr. Szmulewitz’s laboratory is developing strategies to isolate and interrogate circulating tumor cells (CTC) to better understand the biology of prostate cancer, and eventually personalize care based on this individualized biology.

Dr. Szmulewitz is particularly involved in therapeutic development for prostate cancer. He is an investigator on many clinical research trials focusing on immunotherapy, anti-angiogentic, and other novel targeted therapies for prostate cancer.

Practice Location

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice


Board Certifications

Internal Medicine
Medical Oncology

Medical School

Pritzker School of Medicine, University of Chicago

Internship and Residency

New York Medical Center


The University of Chicago Medicine


American Association for Cancer Research
American College of Physicians
American Society of Clinical Oncology
Metastasis Research Society

Language Spoken


Office Phone

(773) 702-7609

Office Fax

(773) 702-3163

Office Postal Address

Russell Szmulewitz, MD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 2115
Chicago, IL 60637

Clinical Interests

Request an appointment online
or call UCM Connect at

Physicians, contact the cancer intake line at (773) 702-8222.

Read More About Dr. Szmulewitz

Learn about how Dr. Szmulewitz and his UChicago Medicine colleagues are investigating new strategies for preventing and treating prostate cancer.

Genetic analysis of Ken Tucker's prostate cancer revealed that he was eligible to participate in a new, targeted treatment available through a Phase I clinical trial. "This is a case where genetics entirely guided the treatment," said Dr. Szmulewitz.

Selected Publications

View a partial list of Dr. Szmulewitz's publications through the National Library of Medicine's PubMed online database.